pharma

Showing 15 posts of 2917 posts found.

Amphista doses first patient in AML trial of protein degrader

October 20, 2026
AML, FDA, Oncology, clinical trial, drug development, pharma

Amphista Therapeutics has dosed the first patient in a phase 1 trial of AMX-883, an experimental oral therapy targeting acute …

Pharma sees climate disruption as growing supply-chain risk

September 11, 2026
British Standards Institution, climate disruption, pharma, supply-chain risk

Nine in ten pharmaceutical companies across the UK and G7 countries expect climate-related disruption to their supply chains to increase …

AI in pharma: From lab development to patient impact

September 5, 2026
AI, Cancer, Immunology, Merck, Vaccine, Virology, personalised medicine, pharma

In the decade to 2025, AI use in vaccine development has increased markedly but is the boom in research translating …

drug-trials

LGC Group opens $100M Organic Chemistry Synthesis Centre of Excellence

September 19, 2025
Medical Communications, Research and Development LGC Group, biotech, life sciences, pharma

LGC Group, a life sciences company, has opened its new Organic Chemistry Synthesis Centre of Excellence in Ontario, Canada after …

blood_test

Johnson & Johnson announces successful results from trial for myeloma treatment

April 16, 2025
Research and Development Johnson & Johnson, Oncology, myeloma, pharma, trial

Global healthcare company, Johnson & Johnson, announced that analysis of its Darzalex (daratumumab) therapy showed significantly longer progression-free survival (PFS) …

ELRIG appoints Del Trezise as chair

April 8, 2025
Research and Development ELRIG, Pharmacy, R&D, drug discovery, non-profit organisation, pharma

ELRIG, a non-profit volunteer-led organisation dedicated to the drug discovery community, has appointed Del Trezise as chair of the board. …

Bend Bioscience adds commercial spray drying facility to Georgia site

April 3, 2025
Manufacturing Services, Manufacturing and Production Bend Bioscience, CDMO, Devices, manufacturing, pharma

Bend Bioscience has announced the addition of a commercial-scale spray dryer and a Gerteis dry granulation system at its facility …

Usama Dar appointed as chief product and technology officer at CluePoints

April 2, 2025
Research and Development Pharmacy, clinical trial analysis, cluepoints, pharma, research and development

CluePoints has appointed Usama Dar as its new chief product and technology officer, effective 1 April 2025. This follows Darโ€™s …

Qfitlia approved by FDA to treat haemophilia A or B

March 31, 2025
Research and Development FDA, Haematology, Sanofi, haemophilia, pharma

The US Food and Drug Administration (FDA) has approved Qfitlia (fitusiran) as the first therapy in the US to treat …

hsm_mobile_clinical_trial_istock-872676342

Medidata launches programme to accelerate therapy delivery

March 31, 2025
Market Research Medidata, Pharmacy, pharma, technology

Medidata has announced the launch of its Medidata Site Insights Program โ€“ a collection of initiatives intended to foster more …

cancer_drip_2

Chiesi announces phase 3 results from enzyme-replacement study

October 29, 2024
Research and Development Internal Medicine, Rare Diseases, chiesi Global rare diseases, clinical trials, pharma, rare diseases

Chiesi Global Rare Diseases have announced the results from their BRIGHT trial, which evaluates the efficacy of enzyme-replacement therapy drug …

Pharma services boom in China as CPHI & PMEC China posts record attendance

August 8, 2024
Conferencing, Events & Incentives, Public Relations, Sales and Marketing CPHI China, PMEC China, pharma

Domestic and international markets in Asia surging as CPHI & PMEC China welcomes a staggering 93,000 attendees 08 August, 2024, …

FDA approves IMIDEXโ€™s AI-powered device VisiRad XR

August 18, 2023
Research and Development FDA, Radiology, pharma, radiology

The technological pharmaceutical company IMIDEX has been granted clearance from the US Food and Drug Administration (FDA) for its artificial …

Artiva Biotherapeutics announces FDA clearance of IND for AlloNK and Rituximab combo

August 17, 2023
Research and Development FDA, IND, Immunology, lupus nephritis, pharma

On 16 August 2023, the US Food and Drug Administration (FDA) officially cleared Artiva Biotherapeuticsโ€™ Investigational New Drug (IND) application …

kidney

Novartis acquires Chinook Therapeutics for $3.5bn

June 12, 2023
Mergers and Acquisitions Chinook Therapeutics, Nephrology, Novartis, kidney disease, pharma

Swiss pharmaceutical company Novartis has entered into an agreement and plan of merger with US-based biopharmaceutical company Chinook Therapeutics for …

The Gateway to Local Adoption Series

Latest content